Story perspectives

DRC Receives First 16,250 Ervebo Ebola Vaccine Doses

8/23/2026

Summary

DRC Receives Vaccine

The Democratic Republic of the Congo received its first 16,250 doses of Merck’s Ervebo Ebola vaccine on August 21, 2026.
WHO allocated 70,000 Ervebo doses to the DRC, designating 20,000 for a Phase 3 trial and 50,000 for frontline workers.
Gavi pledged $13 million—$7 million for vaccine shipment and $6 million to support vaccination in high-risk areas.
The outbreak has caused 2,516 deaths among 5,290 confirmed cases, a roughly 47 % case-fatality rate.

Summary

UN coordinator warns

UN coordinator warned the $80 million response fund will be exhausted within weeks without new financing.
Frontline health workers have protested unpaid wages and bonuses amid the Ebola crisis.
More than 260 attacks on health personnel and facilities have been reported in the past six months.
Only 16% of expected contacts have been traced, far below the target, hindering containment.

1 of 2

DRC Receives Vaccine

The Democratic Republic of the Congo received its first 16,250 doses of Merck’s Ervebo Ebola vaccine on August 21, 2026.
WHO allocated 70,000 Ervebo doses to the DRC, designating 20,000 for a Phase 3 trial and 50,000 for frontline workers.
Gavi pledged $13 million—$7 million for vaccine shipment and $6 million to support vaccination in high-risk areas.
The outbreak has caused 2,516 deaths among 5,290 confirmed cases, a roughly 47 % case-fatality rate.

1 / 2